New York-based chemical company Kronos Bio has secured $105 million in Series A funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced July 18 and led by Omega Funds.
According to its Crunchbase profile, "Kronos Bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets."
The two-year-old startup also raised an $18 million seed round in 2018.
The round brings total funding raised by New York companies in science and engineering over the past month to $167 million, an increase of $127 million from the month before. The local science and engineering industry has produced 194 funding rounds over the past year, yielding a total of $2.9 billion in venture funding.
In other local funding news, database and sustainability company Ethic announced a $13 million Series A funding round on July 18, led by Nyca Partners.
According to Crunchbase, "Ethic creates simple, custom-built, returns-driven passive portfolios for sustainability-focused investors. It is an SEC-registered investment adviser. Past performance is no guarantee of future results."
Founded in 2015, the company has raised five previous rounds, including a $6.8 million round in 2018.
Meanwhile, consulting company Xperiti raised $1 million in seed funding, announced on July 11.
From the company's Crunchbase profile: "Xperiti is a knowledge management platform for enterprise. Banks, hedge funds and consulting firms access Xperiti when they want to gain exclusive insight on a specific field."
Xperiti last raised $20,000 in pre-seed funding earlier this year.
Also of note, electronics and messaging company Abridge raised funding, announced on July 16.
From Crunchbase: "Abridge is a brand and communication strategy firm that offers creative communication and event planning services to its clients. The company’s range of services include advertising, event planning, consultancy, publishing and linguistic localization."
The company previously raised funding in 2000.
Rounding out the city's recent top local funding events, lifestyle company OrthoSnap New York raised funding, announced on July 18 and financed by Loeb.nyc.
From Crunchbase: "OrthoSnap is the newest procedure for teeth straightening in Manhattan and Brooklyn. Now you can straighten your teeth without the cosmetic issues of traditional braces."
The company previously raised $100,000 in seed funding in 2018.
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.
